Sign In
Buy ELAN
$23.89
-0.330 (-1.36%)
At Close: Jun 22, 2026
Activist investor Ancora secures two Elanco board seats, Bloomberg News reports
11:49pm, Sunday, 31'st Mar 2024
Investment firm Ancora Holdings has reached an agreement with Elanco Animal Health to add two of its director candidates to the company's board, Bloomberg News reported late on Sunday, citing people w
Elanco Animal Health (ELAN) CEO on Pet Disease Prevention & Health Products
12:14pm, Monday, 11'th Mar 2024
Elanco Animal Health (ELAN) offers pet disease prevention and nutritional health products. CEO Jeffrey Simmons joins Oliver Renick to give an overview of the company.
Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary
08:33am, Monday, 04'th Mar 2024
GREENFIELD, Ind. , March 4, 2024 /PRNewswire/ -- Elanco Animal Health (NYSE: ELAN) announced today the appointment of Shiv O'Neill as the company's Executive Vice President, General Counsel and Corpor
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
01:08pm, Thursday, 29'th Feb 2024
Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor GREENFIELD, Ind. , Feb. 29, 2024 /PRNewswire/ -- Elanco Animal Health
Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health
08:00am, Thursday, 29'th Feb 2024
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (together with its affiliates, “Ancora” or “we”), which owns approximately 3% of the outstanding common stock of Elanco Animal Health Inc
Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript
11:38am, Monday, 26'th Feb 2024
Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript
Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q4 Earnings
10:31am, Monday, 26'th Feb 2024
The headline numbers for Elanco Animal Health Incorporated (ELAN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key me
Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results
06:27am, Monday, 26'th Feb 2024
Fourth Quarter 2023 Financial Results: Revenue of $1,035 million Reported Net Loss of $141 million, Adjusted Net Income of $39 million Adjusted EBITDA of $165 million or 15.9% of Revenue Reported EPS
Elanco to Participate in Upcoming Investor Conferences
08:00am, Thursday, 22'nd Feb 2024
GREENFIELD, Ind. , Feb. 22, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.
Elanco Animal Health Incorporated (ELAN) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Wednesday, 21'st Feb 2024
Get a deeper insight into the potential performance of Elanco Animal Health Incorporated (ELAN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and exa
Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for
11:05am, Monday, 19'th Feb 2024
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beef 'agtech' company Cattler launches interface with Elanco for its Benchmark program
02:46pm, Thursday, 08'th Feb 2024
SARATOGA, Calif. , Feb. 8, 2024 /PRNewswire/ -- Cattler ( www.cattler.farm ) announces the launch of its interface with Elanco Animal Health Incorporated (NYSE: ELAN), as part of the agreement reached
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2023 Financial Results Announcement
08:00am, Thursday, 08'th Feb 2024
GREENFIELD, Ind. , Feb. 8, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2023 financial results on Monday, February 26, 2024.
Elanco Animal Health sells aqua business to Merck for $1.3 billion
08:24am, Monday, 05'th Feb 2024
Elanco Animal Health Inc has announced the sale of its aqua business to Merck Animal Health for US$1.3 billion in a bid to refocus on other markets. This will enable Elanco to accelerate debt paydown
Elanco Animal Health agrees to sell aqua business to Merck for $1.3 billion in cash
06:43am, Monday, 05'th Feb 2024
Elanco Animal Health Inc. ELAN, -0.41% said Monday it has agreed to sell its aqua business to Merck Animal Health MRK, +0.02% for $1.3 billion in cash. Greenfield, Ind.
